Ovid Therapeutics Inc. buy BiotechBee
Start price
28.09.25
/
70%
€1.50
Target price
30.09.27
€5.00
Performance (%)
60.00%
End price
19.04.26
€2.40
Summary
This prediction ended on 19.04.26 with a price of €2.40. With a performance of 60.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ovid Therapeutics Inc. | - | - |
| iShares Core DAX® | 0,27 % | 2,50 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % |
| iShares S&P 500 | 0,15 % | 1,92 % |
According to BiotechBee what are the pros and cons of Ovid Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ovid Therapeutics Inc. diskutieren
In the thread Trading Ovid Therapeutics Inc.
Stopped prediction by BiotechBee for Ovid Therapeutics Inc.
Ovid Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.50
20.07.25
20.07.25
€2.00
20.07.26
20.07.26
118.00%
29.08.25
29.08.25
Could be very worthwhile Investment >20% year
Ovid Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.95
14.12.24
14.12.24
€3.00
30.11.26
30.11.26
-69.10%
30.03.25
30.03.25
Could be very worthwhile Investment >20% year